Wegovy FlexTouch is a prescription-only weight management medicine containing semaglutide. It works by helping regulate appetite, reducing hunger and increasing feelings of fullness. Wegovy is used alongside a reduced-calorie diet and increased physical activity.
Key Features
- Contains semaglutide, a GLP-1 receptor agonist.
- Available in five strengths: 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg.
- Administered as a once-weekly injection.
- Each FlexTouch pen contains four doses and is supplied with four disposable needles.
- Different strengths are used as treatment progresses, according to the prescribed dosing schedule.
Who Is This Product For?
Wegovy is used for weight management in eligible adults with obesity, or those who are overweight with at least one weight-related health condition. It may also be prescribed to eligible adolescents aged 12 years and over. Treatment requires an appropriate clinical assessment and a valid prescription.
How to Use
Wegovy is injected once weekly under the skin of the abdomen, thigh or upper arm. It can be administered at any time of day, with or without meals. The dose is normally increased gradually to help reduce gastrointestinal side effects.
Usual dose escalation schedule:
- Weeks 1–4: 0.25mg once weekly.
- Weeks 5–8: 0.5mg once weekly.
- Weeks 9–12: 1mg once weekly.
- Weeks 13–16: 1.7mg once weekly.
- Week 17 onwards: 2.4mg once weekly.
Always follow the dosing instructions provided by your prescriber. Do not increase your dose or change your treatment schedule without medical advice.
Storage & Handling
- Before first use, store in a refrigerator at 2°C–8°C.
- Do not freeze or use if the medicine has been frozen.
- After first use, the pen may be stored below 30°C or refrigerated for up to six weeks.
- Keep the pen cap on when not in use to protect the medicine from light.
- Use a new needle for each injection and dispose of used needles safely.
- Keep out of the sight and reach of children.
Possible Side Effects
Common side effects include nausea, vomiting, diarrhoea, constipation, headache and stomach discomfort. These effects may be more noticeable when starting treatment or increasing the dose.
Seek urgent medical attention if you experience severe, persistent abdominal pain, which may indicate pancreatitis, or symptoms of a serious allergic reaction. Vomiting and diarrhoea can cause dehydration, so maintaining adequate fluid intake is important.
Warnings & Precautions
- Do not use if you are allergic to semaglutide or any other ingredient.
- Wegovy must not be used during pregnancy or breastfeeding.
- Inform your prescriber if you have diabetes, kidney problems, a history of pancreatitis or diabetic eye disease.
- Tell your healthcare professional about all medicines you take, particularly insulin or sulfonylureas, which may increase the risk of low blood sugar.
- Inform your healthcare team before any planned surgery or procedure involving anaesthesia or deep sedation.
- Do not use Wegovy together with other medicines containing semaglutide or other GLP-1 receptor agonists unless specifically directed by an appropriate clinician.
Important Information
Wegovy is a prescription-only medicine. Supply through Chrystalls Connect requires a completed weight-loss consultation, a valid prescription and pharmacist approval. Patients requesting further treatment must provide their Patient ID and the relevant details so their prescription and requested strength can be checked against pharmacy records.
Orders are subject to clinical verification and stock availability. Treatment must only be supplied when clinically appropriate and authorised.
Patient Information Leaflet
Always read the manufacturer’s patient information leaflet before using Wegovy FlexTouch.





Reviews
There are no reviews yet.